UniProt ID | LEMD2_HUMAN | |
---|---|---|
UniProt AC | Q8NC56 | |
Protein Name | LEM domain-containing protein 2 | |
Gene Name | LEMD2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 503 | |
Subcellular Localization |
Nucleus inner membrane Multi-pass membrane protein . Lamina-associated protein residing in the inner nuclear membrane (INM). Localized exclusively to the nuclear envelope, giving rise to a typical rim-like staining of the nuclear periphery. |
|
Protein Description | Involved in nuclear structure organization. [PubMed: 16339967 Required for maintaining the integrity of the nuclear envelope] | |
Protein Sequence | MAGLSDLELRRELQALGFQPGPITDTTRDVYRNKLRRLRGEARLRDEERLREEARPRGEERLREEARLREDAPLRARPAAASPRAEPWLSQPASGSAYATPGAYGDIRPSAASWVGSRGLAYPARPAQLRRRASVRGSSEEDEDARTPDRATQGPGLAARRWWAASPAPARLPSSLLGPDPRPGLRATRAGPAGAARARPEVGRRLERWLSRLLLWASLGLLLVFLGILWVKMGKPSAPQEAEDNMKLLPVDCERKTDEFCQAKQKAALLELLHELYNFLAIQAGNFECGNPENLKSKCIPVMEAQEYIANVTSSSSAKFEAALTWILSSNKDVGIWLKGEDQSELVTTVDKVVCLESAHPRMGVGCRLSRALLTAVTNVLIFFWCLAFLWGLLILLKYRWRKLEEEEQAMYEMVKKIIDVVQDHYVDWEQDMERYPYVGILHVRDSLIPPQSRRRMKRVWDRAVEFLASNESRIQTESHRVAGEDMLVWRWTKPSSFSDSER | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAGLSDLEL ------CCCCCHHHH | 27.86 | 22814378 | |
5 | Phosphorylation | ---MAGLSDLELRRE ---CCCCCHHHHHHH | 38.95 | 23401153 | |
10 | Methylation | GLSDLELRRELQALG CCCHHHHHHHHHHCC | 22.20 | 115482009 | |
26 | Phosphorylation | QPGPITDTTRDVYRN CCCCCCCHHHHHHHH | 18.32 | 28555341 | |
27 | Phosphorylation | PGPITDTTRDVYRNK CCCCCCHHHHHHHHH | 27.90 | 25627689 | |
82 | Phosphorylation | RARPAAASPRAEPWL CCCCCCCCCCCCCCC | 15.36 | 22115753 | |
90 | Phosphorylation | PRAEPWLSQPASGSA CCCCCCCCCCCCCCC | 30.19 | 26074081 | |
94 | Phosphorylation | PWLSQPASGSAYATP CCCCCCCCCCCCCCC | 39.71 | 29978859 | |
96 | Phosphorylation | LSQPASGSAYATPGA CCCCCCCCCCCCCCC | 18.66 | 28796482 | |
98 | Phosphorylation | QPASGSAYATPGAYG CCCCCCCCCCCCCCC | 16.83 | 28796482 | |
100 | Phosphorylation | ASGSAYATPGAYGDI CCCCCCCCCCCCCCC | 15.02 | 28796482 | |
104 | Phosphorylation | AYATPGAYGDIRPSA CCCCCCCCCCCCHHH | 22.65 | 28796482 | |
108 | Methylation | PGAYGDIRPSAASWV CCCCCCCCHHHHHHH | 24.70 | 82797205 | |
110 | Phosphorylation | AYGDIRPSAASWVGS CCCCCCHHHHHHHCC | 26.98 | 24173317 | |
113 | Phosphorylation | DIRPSAASWVGSRGL CCCHHHHHHHCCCCC | 23.24 | 24173317 | |
117 | Phosphorylation | SAASWVGSRGLAYPA HHHHHHCCCCCCCCC | 17.35 | 24173317 | |
122 | Phosphorylation | VGSRGLAYPARPAQL HCCCCCCCCCCHHHH | 11.50 | 28152594 | |
134 | Phosphorylation | AQLRRRASVRGSSEE HHHHHHHHCCCCCCC | 15.55 | 22167270 | |
138 | Phosphorylation | RRASVRGSSEEDEDA HHHHCCCCCCCCCCC | 24.82 | 29255136 | |
139 | Phosphorylation | RASVRGSSEEDEDAR HHHCCCCCCCCCCCC | 48.07 | 29255136 | |
147 | Phosphorylation | EEDEDARTPDRATQG CCCCCCCCCCCCCCC | 31.12 | 22167270 | |
152 | Phosphorylation | ARTPDRATQGPGLAA CCCCCCCCCCCCHHH | 34.65 | - | |
166 | Phosphorylation | ARRWWAASPAPARLP HHHHHHCCCCCCCCC | 17.53 | 23927012 | |
174 | Phosphorylation | PAPARLPSSLLGPDP CCCCCCCHHHHCCCC | 37.90 | 29255136 | |
175 | Phosphorylation | APARLPSSLLGPDPR CCCCCCHHHHCCCCC | 26.18 | 29255136 | |
188 | Phosphorylation | PRPGLRATRAGPAGA CCCCCCCCCCCCCCH | 18.02 | 23403867 | |
192 | Ubiquitination | LRATRAGPAGAARAR CCCCCCCCCCHHHCC | 26.91 | 21890473 | |
264 | Ubiquitination | TDEFCQAKQKAALLE CHHHHHHHHHHHHHH | 26.84 | - | |
264 | Methylation | TDEFCQAKQKAALLE CHHHHHHHHHHHHHH | 26.84 | - | |
266 | Methylation | EFCQAKQKAALLELL HHHHHHHHHHHHHHH | 34.61 | - | |
319 | Acetylation | VTSSSSAKFEAALTW CCCCCCHHHHHHHHH | 45.76 | 7710437 | |
352 | Acetylation | ELVTTVDKVVCLESA HEEEEECEEEECCCC | 32.03 | 26051181 | |
436 | Phosphorylation | WEQDMERYPYVGILH HHHHHHHCCEEEEEE | 5.89 | 22817900 | |
438 | Phosphorylation | QDMERYPYVGILHVR HHHHHCCEEEEEEEC | 11.45 | - | |
453 | Phosphorylation | DSLIPPQSRRRMKRV HHCCCHHHHHHHHHH | 33.26 | 26462736 | |
470 | Phosphorylation | RAVEFLASNESRIQT HHHHHHHCCCHHCCC | 43.19 | 23312004 | |
473 | Phosphorylation | EFLASNESRIQTESH HHHHCCCHHCCCCHH | 38.64 | 23312004 | |
477 | Phosphorylation | SNESRIQTESHRVAG CCCHHCCCCHHHCCC | 36.76 | - | |
479 | Phosphorylation | ESRIQTESHRVAGED CHHCCCCHHHCCCCC | 21.71 | - | |
493 | Phosphorylation | DMLVWRWTKPSSFSD CEEEEEECCCCCCCC | 25.22 | 22167270 | |
494 | Ubiquitination | MLVWRWTKPSSFSDS EEEEEECCCCCCCCC | 35.62 | 21890473 | |
496 | Phosphorylation | VWRWTKPSSFSDSER EEEECCCCCCCCCCC | 45.64 | 22167270 | |
497 | Phosphorylation | WRWTKPSSFSDSER- EEECCCCCCCCCCC- | 36.98 | 22167270 | |
499 | Phosphorylation | WTKPSSFSDSER--- ECCCCCCCCCCC--- | 42.02 | 29255136 | |
501 | Phosphorylation | KPSSFSDSER----- CCCCCCCCCC----- | 33.79 | 29255136 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LEMD2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LEMD2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LEMD2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of LEMD2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138 AND SER-139, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134; SER-138; SER-139;SER-166 AND SER-499, AND MASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499, AND MASSSPECTROMETRY. |